Local action of endogenous renal tubular atrial natriuretic peptide

Journal of Cellular Physiology

Volumn 219, Issue 3, 2009, Pages 776-786

  Lo, Chao Sheng ^a   Chen, Chao Hung ^a   Hsieh, Tusty Jiuan ^b   Lin, Kun Der ^a,c   Hsiao, P I Jung ^c   Shin, Shyi Jang ^b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; COLLAGEN TYPE 1; GLUCOSE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; ATRIAL NATRIURETIC PEPTIDE, RAT; PRIMER DNA; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; GENETIC TRANSFECTION; HYPERGLYCEMIA; KIDNEY TUBULE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENE SILENCING; GENETICS; KIDNEY TUBULE; METABOLISM;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BASE SEQUENCE; CELL LINE; COLLAGEN TYPE I; CULTURE MEDIA, CONDITIONED; DNA PRIMERS; GENE EXPRESSION; GENE SILENCING; GLUCOSE; KIDNEY TUBULES; NF-KAPPA B; RATS; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 64549155705     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21728     Document Type: Article

References (41)

1. Bae EH, Kim IJ, Park JW, Ma SK, Choi KC, Lee JU, Kim SW. 2007. Altered regulation of renin-angiotensin, endothelin and natriuretic peptide systems in rat kidney with chronic unilateral ureteral obstruction. Urol Int 79:170-176. (Pubitemid 47402745)
2. Baldini PM, De Vito P, D'Aquilio F, Vismara D, Zalfa F, Bagni C, Fiaccavento R, Di Nardo P. 2005. Role of atrial natriuretic peptide in the suppression of lysophosphatydic acid-induced rat aortic smooth muscle (RASM) cell growth. Mol Cell Biochem 272:19-28. (Pubitemid 40867361)
3. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Kloting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Haring HU, Schleicher E, Nawroth PP. 2001. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50:2792-2808.
4. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. 1990. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70:665-699. (Pubitemid 20196047)
5. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. 1981. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28:89-94. (Pubitemid 11184926)
6. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. 2002. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev 23:599-622. (Pubitemid 35191625)
7. Gerbes AL, Vollmar AM, Kiemer AK, Bilzer M. 1998. The guanylate cyclase-coupled natriuretic peptide receptor: A new target for prevention of cold ischemia-reperfusion damage of the rat liver. Hepatology 28:1309-1317. (Pubitemid 28493842)
8. Gilbert RE, Cox A, Wu LL, Allen TJ, Hulthen UL, Jerums G, Cooper ME. 1998. Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: Effects of ACE inhibition. Diabetes 47:414-422. (Pubitemid 28104204)
9. Guijarro C, Egido J. 2001. Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int 59:415-424. (Pubitemid 32157906)
10. Hannken T, Schroeder R, Stahl RA, Wolf G. 2001. Atrial natriuretic peptide attenuates ANG II-induced hypertrophy of renal tubular cells. Am J Physiol Renal Physiol 281:F81-90. (Pubitemid 32911874)
11. Hill C, Flyvbjerg A, Gronbaek H, Petrik J, Hill DJ, Thomas CR, Sheppard MC, Logan A. 2000. The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats. Endocrinology 141:1196-1208. (Pubitemid 32260463)
12. Irwin DC, Tissot van Patot MC, Tucker A, Bowen R. 2005. Direct ANP inhibition of hypoxia-induced inflammatory pathways in pulmonary microvascular and macrovascular endothelial monolayers. Am J Physiol Lung Cell Mol Physiol 288:L849-L859. (Pubitemid 40547910)
13. IwanoM, Kubo A, Nishino T, Sato H, Nishioka H, Akai Y, Kurioka H, Fujii Y, Kanauchi M, Shiiki H, Dohi K. 1996. Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus. Kidney Int 49:1120-1126. (Pubitemid 26122715)
14. Kato T, Muraski J, Chen Y, Tsujita Y, Wall J, Glembotski CC, Schaefer E, Beckerle M, Sussman MA. 2005. Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J Clin Invest 115:2716-2730. (Pubitemid 41434399)
15. Kiemer AK, Vollmar AM. 2001. The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages. Ann Rheum Dis 60:iii68-iii70. (Pubitemid 32980449)
16. Kiemer AK, Vollmar AM, Bilzer M, Gerwig T, Gerbes AL. 2000. Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1. J Hepatol 33:236-246. (Pubitemid 30485227)
17. Kiemer AK, Weber NC, Vollmar AM. 2002. Induction of IkappaB: Atrial natriuretic peptide as a regulator of the NF-kappaB pathway. Biochem Biophys Res Commun 295:1068-1076. (Pubitemid 34936887)
18. Kiemer AK, Bildner N, Weber NC, Vollmar AM. 2003. Characterization of heme oxygenase 1 (heat shock protein 32) induction by atrial natriuretic peptide in human endothelial cells. Endocrinology 144:802-812. (Pubitemid 36262847)
19. Kishimoto I, Rossi K, Garbers DL. 2001. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci USA 98:2703-2706. (Pubitemid 32209546)
20. Lai FJ, Shin SJ, Lee YJ, Lin SR, Jou WY, Tsai JH. 2000. Up-regulation of adrenal cortical and medullary atrial natriuretic peptide and gene expression in rats with deoxycorticosterone acetate-salt treatment. Endocrinology 141:325-332. (Pubitemid 32260374)
21. Lai FJ, Hsieh MC, Hsin SC, Lin SR, Guh JY, Chen HC, Shin SJ. 2002. The cellular localization of increased atrial natriuretic peptide mRNA and immunoreactivity in diabetic rat kidneys. J Histochem Cytochem 50:1501-1508. (Pubitemid 36024898)
22. Li JH, Huang XR, Zhu HJ, Johnson R, Lan HY. 2003. Role of TGF-beta signaling in extracellular matrix production under high glucose conditions. Kidney Int 63:2010-2019. (Pubitemid 36605812)
23. Lo CS, Chen ZH, Hsieh TJ, Shin SJ. 2008. Atrial natriuretic peptide attenuates high glucose-activated transforming growth factor-beta, Smad and collagen synthesis in renal proximal tubular cells. J Cell Biochem 103:1999-2009.
24. Mezzano S, Aros C, Droguett A, Burgos ME, Ardiles L, Flores C, Schneider H, Ruiz-Ortega M, Egido J. 2004. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 19:2505-2512. (Pubitemid 39360096)
25. Mistry S, Lussert B, Stewart K, Hawksworth GM, Struthers A, McLay JS. 2000. The expression and secretion of atrial natriuretic factor and brain natriuretic peptide by rat proximal tubular cells. Biochem Pharmacol 59:783-790. (Pubitemid 30081701)
26. Nishikimi T, Maeda N, Matsuoka H. 2006. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 69:318-328. (Pubitemid 43098788)
27. Obineche E, Chandranath I, Adeghate E, Benedict S, Fahim M, Adem A. 2006. Alterations in atrial natriuretic peptide and its receptor levels in long-term, streptozotocin-induced, diabetes in rats. Ann NY Acad Sci 1084:223-234. (Pubitemid 47091958)
28. Ogawa T, Linz W, Scholkens BA, de Bold AJ. 1999. Variable renal atrial natriuretic factor gene expression in hypertension. Hypertension 33:1342-1347. (Pubitemid 29282651)
29. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N. 1997. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94:14730-14735. (Pubitemid 28041442)
30. Polte T, Hemmerle A, Berndt G, Grosser N, Abate A, Schroder H. 2002. Atrial natriuretic peptide reduces cyclosporin toxicity in renal cells: Role of cGMP and heme oxygenase-1. Free Radic Biol Med 32:56-63. (Pubitemid 34045137)
31. Roson MI, Toblli JE, Della Penna SL, Gorzalczany S, Pandolfo M, Cavallero S, Fernandez BE. 2006. Renal protective role of atrial natriuretic peptide in acute sodium overload-induced inflammatory response. Am J Nephrol 26:590-601. (Pubitemid 46143881)
32. Sharma K, Ziyadeh FN. 1995. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44:1139-1146.
33. Shin SJ, Lee YJ, Tan MS, Hsieh TJ, Tsai JH. 1997. Increased atrial natriuretic peptide mRNA expression in the kidney of diabetic rats. Kidney Int 51:1100-1105. (Pubitemid 27186535)
34. Shin SJ, Wen JD, Chen IH, Lai FJ, Hsieh MC, Hsieh TJ, Tan MS, Tsai JH. 1998. Increased renal ANP synthesis, but decreased or unchanged cardiac ANP synthesis in water-deprived and salt-restricted rats. Kidney Int 54:1617-1625. (Pubitemid 28502904)
35. Totsune K, Mackenzie HS, Totsune H, Troy JL, Lytton J, Brenner BM. 1998. Upregulation of atrial natriuretic peptide gene expression in remnant kidney of rats with reduced renal mass. J Am Soc Nephrol 9:1613-1619. (Pubitemid 28405068)
36. Tsukagoshi H, Shimizu Y, Kawata T, Hisada T, Shimizu Y, Iwamae S, Ishizuka T, Iizuka K, Dobashi K, Mori M. 2001. Atrial natriuretic peptide inhibits tumor necrosis factoralpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and nuclear factor-kappa B activation. Regul Pept 99:21-29. (Pubitemid 32232124)
37. Vellaichamy E, Sommana NK, Pandey KN. 2005. Reduced cGMP signaling activates NF-kappaB in hypertrophied hearts of mice lacking natriuretic peptide receptor-A. Biochem Biophys Res Commun 327:106-111. (Pubitemid 40051358)
38. Vellaichamy E, Kaur K, Pandey KN. 2007. Enhanced activation of pro-inflammatory cytokines in mice lacking natriuretic peptide receptor-A. Peptides 28:893-899. (Pubitemid 46349326)
39. Vollmar AM. 2005. The role of atrial natriuretic peptide in the immune system. Peptides 26:1086-1094. (Pubitemid 40725379)
40. Wolf G, Ziyadeh FN. 2007. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol 106:26-31. (Pubitemid 46920097)
41. Yang WS, Seo JW, Han NJ, Choi J, Lee KU, Ahn H, Lee SK, Park SK. 2008. High glucose-induced NF-kappaB activation occurs via tyrosine phosphorylation of IkappaBalpha in human glomerular endothelial cells: Involvement of Syk tyrosine kinase. Am J Physiol Renal Physiol 294:F1065-1075.